| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |